{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:53Z","timestamp":1786998473493,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO1003"],"award-info":[{"award-number":["01EO1003"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ymgme.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T23:58:32Z","timestamp":1584575912000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A non-invasive diagnostic assay for rapid detection and characterization of aberrant mRNA-splicing by nonsense mediated decay inhibition"],"prefix":"10.1016","volume":"130","author":[{"given":"Friederike","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyfullah","family":"G\u00f6kce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesa","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Danckwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Sollfrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Neukirch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Rossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.03.002_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.75","article-title":"From cryptic toward canonical pre-mRNA splicing in Pompe disease: A pipeline for the development of antisense oligonucleotides","volume":"5","author":"Bergsma","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Abramowicz","year":"2018","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1327","article-title":"Genomic variants in exons and introns: identifying the splicing spoilers","volume":"5","author":"Pagani","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1126\/science.8430317","article-title":"The skipping of constitutive exons in vivo induced by nonsense mutations","volume":"259","author":"Dietz","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/CS20160211","article-title":"RNA splicing in human disease and in the clinic","volume":"131","author":"Baralle","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8669-9_1","article-title":"Identification and analysis of genes associated with inherited retinal diseases","volume":"1834","author":"Khan","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"Holbrook","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2016.05.053","article-title":"Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine","volume":"165","author":"Popp","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.ircmb.2017.07.008","article-title":"Alternative splicing in genetic diseases: improved diagnosis and novel treatment options","volume":"335","author":"Bergsma","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1073\/pnas.0136770100","article-title":"Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans","volume":"100","author":"Lewis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/88099","article-title":"A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition","volume":"19","author":"Noensie","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/humu.22624","article-title":"Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions","volume":"35","author":"Sharma","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ajhg.2017.04.001","article-title":"Systematic computational identification of variants that activate exonic and intronic cryptic splice sites","volume":"100","author":"Lee","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ejhg.2010.188","article-title":"Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes","volume":"19","author":"Zampieri","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.22108","article-title":"Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants","volume":"33","author":"Kroos","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22705","article-title":"Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach","volume":"36","author":"Bergsma","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/genes9020073","article-title":"Impact, characterization, and rescue of pre-mRNA splicing mutations in lysosomal storage disorders","volume":"9","author":"Dardis","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0100","first-page":"3","article-title":"A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan","volume":"14","author":"Fukuhara","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0105","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/humu.23867","article-title":"Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology","volume":"40","author":"Goina","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007723","article-title":"Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis","volume":"14","author":"Sharma","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-7-35","article-title":"A cross-sectional single-Centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations","volume":"7","author":"Herzog","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0120","article-title":"Human T lymphocyte isolation, culture and analysis of migration in vitro","volume":"2017","author":"Lefort","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"M\u00fcller-Felber","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0135","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0140","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1182\/blood.V99.5.1811","article-title":"Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay","volume":"99","author":"Danckwardt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0145","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/emboj\/20.7.1785","article-title":"SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs","volume":"20","author":"Sureau","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10549-011-1599-7","article-title":"Characterisation of unclassified variants in the BRCA1\/2 genes with a putative effect on splicing","volume":"129","author":"Brand\u00e3o","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymeth.2019.01.003","article-title":"Inhibiting transcription in cultured metazoan cells with actinomycin D to monitor mRNA turnover","volume":"155","author":"Lai","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0160","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(08)02617-7","article-title":"Chapter 17: Messenger RNA half-life measurements in mammalian cells","author":"Chen","year":"2008"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1017\/cjn.2016.37","article-title":"Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian expert panel","volume":"43","author":"Tarnopolsky","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0170","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ymthe.2017.05.019","article-title":"Glycogen reduction in myotubes of late-onset Pompe disease patients using antisense technology","volume":"25","author":"Goina","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtn.2017.03.001","article-title":"Antisense oligonucleotides promote exon inclusion and correct the common c.-32-13TG GAA splicing variant in Pompe disease","volume":"7","author":"van der Wal","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0180","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2174\/1381612823666161122142950","article-title":"Therapeutic suppression of nonsense mutation: an emerging target in multiple diseases and thrombotic disorders","volume":"23","author":"Asiful Islam","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/wrna.1357","article-title":"Nonsense-mediated mRNA decay: novel mechanistic insights and biological impact","volume":"7","author":"Karousis","year":"2016","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biocel.2017.07.013","article-title":"The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease","volume":"91","author":"da Costa","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2020.03.002_bb0195","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymgme.2020.03.002_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: clinical spectrum and genotype in 31 patients","volume":"11","author":"van Capelle","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"2019","key":"10.1016\/j.ymgme.2020.03.002_bb0205","article-title":"Extension of the Pompe mutation database by linking disease-associated variants to clinical severity","volume":"40","author":"Ni\u00f1o","year":"1954","journal-title":"Hum. Mutat."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:50Z","timestamp":1761089090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220300615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1096719220300615"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.03.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-invasive diagnostic assay for rapid detection and characterization of aberrant mRNA-splicing by nonsense mediated decay inhibition","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}